16. Veterans & Psychedelics part 2 – Aya...

Join us in this episode as we speak with Emma Robinson, a professor of psychopharmacology at the University of Bristol with extensive experience in animal research. She unpacks the regulations surrounding animal research, offering a scientist’s view on animal rights activism, eth ... Show More

<p>In this episode of the Drug Science Podcast, we talk to Simon Doherty, a journalist and content creator with a focus on harm reduction. He explores how reporting on electronic music and rave culture naturally led to his work on harm reduction. He goes on to dissect Talk to Fra ... Show More

Join us in this episode as we talk to Prof Sara Tai, a professor of clinical psychology at the University of Manchester and an NHS consultant clinical psychologist. Sara’s research is grounded in biopsychosocial frameworks, with a focus on understanding the mechanisms of change t ... Show More

<p>In this episode, Kyle and Joe interview Ben Sessa, a Consultant Psychiatrist. Ben comes on the show to talk about preliminary results from the first ever, MDMA assisted therapy for alcohol use disorder (AUD).<strong><br /></strong></p> <h1>3 Key Points:</h1> <ol> <li>Ben Sessa ... Show More

<p>For 37 years, Rick Doblin has been pushing the F.D.A. to approve treating post-traumatic stress disorder with MDMA, better known as Ecstasy. He tells Steve why he persisted for so long, why he doesn’t like calling drug use “recreational,” and what he learned from his pet wolf. ... Show More

<p>In this episode, Joe interviews Maya Albert: Co-Founder of the Psyched conference, and Director of Operations at Tabula Rasa Ventures and the Synthesis Institute.</p> <p>She shares her journey of how she became involved in the psychedelic space through her mother, and her pers ... Show More

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ... Show More

The relentless pursuit of pleasure always leads to pain. As the world evolves from one of scarcity to overabundance, we increasingly orient our lives around the pursuit of pleasure and avoidance of pain—an instinct that has produced a myriad of unprecedented types of addiction, a ... Show More

"Antipsychiatry," Esalen, psychedelics, and DSM III: Radical challenges to psychiatry and the conventional treatment of mental health in the 1970s. The upheavals of the 1960s gave way to a decade of disruptions in the 1970s, and among the rattled fixtures of American society was ... Show More

Today’s episode is with Rick Doblin Ph.D., the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of t ... Show More

This episode is brought to you by Rupa Health, InsideTracker, and LMNT. Compounds that have long been considered recreational drugs by conventional standards are finally being recognized through science as powerful tools for overcoming hard-to-treat health issues like PTSD, depre ... Show More

When you look at the world, it can feel like we're in a precarious moment. If you’ve listened to past episodes, you know we call this the meta-crisis — an era of overlapping and interconnected crises like climate change, polarization, and the rise of decentralized technologies li ... Show More

<p>Psychedelic drugs have been illegal for 50 years, but they’re trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges.</p> <p>We begin the hour with reporter <a href="https://radio.jdavis. ... Show More